Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-436-5 | CAS number: 528-50-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from Dec 6, 2021, to Feb 14, 2022
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
- Report date:
- 2022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- version of June 18, 2019
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- D-cellobiose
- EC Number:
- 208-436-5
- EC Name:
- D-cellobiose
- Cas Number:
- 528-50-7
- Molecular formula:
- C12H22O11
- IUPAC Name:
- (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)- 4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source (i.e. manufacturer or supplier) and lot/batch number of test material: Pfeifer & Langen GmbH & Co. KG; Lot No. L1021174
- Purity, including information on contaminants, isomers, etc.: 99.54 %
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: at room temperature, protected from light
- Expiry date: 28 October 2023
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing (e.g. warming, grinding): none
Test animals / tissue source
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability: The EpiOcularTM Eye Irritation Test (EIT) was validated and is scientifically valid to identify chemicals that do not require classification for eye irritation or serious eye damage according to UN GHS (UN GHS No Category) without further testing. Solids are within the applicability domain of the test method
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell live:
EpiOcularTM (OCL-200-EIT)
The EpiOcularTM human cell construct (MatTek In Vitro Life Science Laboratories) is used in this assay. This three-dimensional human cornea model allows the identification of test items with the potential to induce eye irritation or serious eye damage by assessing cell viability after treatment. The model is composed of stratified human keratinocytes in a three- dimensional structure, consisting of at least three viable layers of cells. Test materials can be applied topically to the model so that water insoluble materials may also be tested. Prior to use, each plate (6, 12, and 24-well) and its cover was uniquely identified with a permanent marker by a plate number and/or test item number.
The cytotoxicity of the test item (and thus the ocular irritation potential) is evaluated by the relative viability of the treated tissues in comparison to the negative control-treated tissues. Viability is determined by the NAD(P)H-dependent microsomal enzyme reduction of MTT (and to a lesser extent, by the succinate dehydrogenase reduction of MTT) in control and test item-treated cultures (Berridge, et al., 1996). Data are presented in the form of relative survival (relative MTT conversion).
Supplier: MatTek In Vitro Life Science Laboratories Mlynské Nivy 73, Bratislava, Slovakia
Lot No.: 34945
Expiry date: 10 December 2021
-Demonstration of Proficiency
Prior to routine use of the method TOXI-COOP ZRT. Demonstrated the technical proficiency in a separate study (Study No.: 392-492-1722) using the fifteen Proficiency Chemicals according to OECD Test Guideline No. 492.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): approx. 50 mg/tissue
- Concentration (if solution): not applicable
- Duration of treatment / exposure:
- 6h
- Duration of post- treatment incubation (in vitro):
- 18h
- Number of animals or in vitro replicates:
- 2 tissues
- Details on study design:
- - Details of the test procedure used: The test was conducted according to the OCED TG 492 (details below)
- RhCE tissue construct used, including batch number: Kit OCL-200; Lot no.: 34945
- Doses of test chemical and control substances used: approx. 50 mg/tissue
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods (where applicable): Exposure of 6h at approx. 37°C; 25 min post soak at room temperature; and 18h post-incubation at approx. 37°C
- Justification for the use of a different negative control than ultrapure H2O (if applicable): not applicable
- Justification for the use of a different positive control than neat methyl acetate (if applicable): not applicable
- Description of any modifications to the test procedure: none
- Indication of controls used for direct MTT-reducers and/or colouring test chemicals (if applicable): In a pre-test, no indication for direct MTT reduction or colouring by the test substance was observed.
- Number of tissue replicates used per test chemical and controls (positive control, negative control, NSMTT, NSCliving and NSCkilled, if applicable): 2
- Wavelength and band pass (if applicable) used for quantifying MTT formazan, and linearity range of measuring device (e.g. spectrophotometer): 570 nm
- Description of the method used to quantify MTT formazan: spectrophotometer
- Description of the qualification of the HPLC/UPLC-spectrophotometry system (if applicable): not applicable
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model: The evaluation criteria of the OECD TG 492%, i.e. a threshold of 60% to discriminate non eye irritants from eye irritants, were used.
- Reference to historical positive and negative control results demonstrating suitable run acceptance criteria: Both the responses of the negative and the positive controls were within the range of the historical data.
- Complete supporting information for the specific RhCE tissue construct used: see above
- Reference to historical data of the RhCE tissue construct: Acceptable OD range of negative control: 1.094 - 2.609; acceptable relative viability range of the positive control: 2 - 41%
- Demonstration of proficiency in performing the test method before routine use by testing of the proficiency chemicals: Prior to routine use of the method TOXI-COOP ZRT. Demonstrated the technical proficiency in a separate study (Study No.: 392-492-1722) using the fifteen Proficiency Chemicals according to OECD Test Guideline No. 492.
- Acceptable variability between tissue replicates for positive and negative controls: Yes (5% and 1%)
- Acceptable variability between tissue replicates for the test chemical: Yes (5%)
Results and discussion
In vitro
Results
- Irritation parameter:
- mean percent tissue viability
- Run / experiment:
- Experiment 1
- Value:
- 90
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: none
DEMONSTRATION OF TECHNICAL PROFICIENCY:
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes
- Acceptance criteria met for positive control: yes
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In a valid experimental study according to OECD test guideline 492 under GLP conditions, the test substance marginally reduced the cell viability (90%). Therefore, it is considered as not irritating to the eye.
- Executive summary:
The eye irritation potential of the test substance was investigated in an experimental study according to OECD test guideline 492 under GLP conditions using the EpiOcularTM tissue. The EpiOcularTM tissue is provided in kits, which are manufactures according to defined quality assurance procedures.
The testing laboratory, which had demonstrated its technical proficiency in conducting the test, received the kit used for testing in good order.
The test substance was applied (approx. 50 mg) for six hours to two tissues. After thorough rinsing, 25 min post soak at room temperature was performed, before the tissues were post-incubated for 18h post-incubation at approx. 37°C. Then the MTT test was performed and cell viability was measured with a spectrometer at 570 nm.
Concurrent negative and positive control fulfilled all acceptance criteria, as did the test substance, which did not directly reduce MTT, nor was colour interfering.
The test substance marginally reduced the cell viability as compared to the negative control (90.0%).
The results obtained from the study indicated that the test item reveals no eye irritation potential under the applied testing conditions. According to the current OECD Guideline No. 492, cellobiose is, thus, considered as non-irritant to eye (UN GHS No Category).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.